IP Barriers Block Pfizer Following US Pegfilgrastim Approval

Sixth Oncology Biosimilar Approval Chalked Up

 
• By Dean Rudge
  
PfizerSign
Pfizer's biosimilar portfolio now includes six FDA-approved oncology products • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products